Fixed Income Manager Finds Agency MBS Attractive Right Now
September 08, 2024
Hauter, Amy
Seeking Out Game Changers in Re-Emerging Biotech Sector
April 18, 2024
Bayko, Liisa
Smart Pills Deliver Drug Benefits with Fewer Side Effects
November 12, 2023
Vandermosten, John
Three Large-Cap Biotechs That Stand Out in an Uncertain Market
April 06, 2023
Singh, Hartaj
Next-Generation Immune-Oncology Drugs Show Early Promise
March 30, 2023
Phipps, Matt
Uncovering Bargains: Neglected Stocks with Positive Momentum
March 05, 2023
Nesbitt, Donald J.
Rising Interest Rates Pose Headwind for Biotechs Needing Cash
March 18, 2022
Phipps, Matt
Gene Editing Companies Enjoy Momentum While Gene Therapies Lag
September 30, 2021
Livshits, Geulah
Consumers Splurge on Aesthetic Procedures Post Pandemic
September 30, 2021
Cooley, Chris
Early-Stage Anti-Inflammatory Drugs May Provide Breakthrough Treatments
September 30, 2021
Brozak, Steve
D.C. Drug Price Debate Creates Opportunity for Longer-Term Pharma Investors
September 30, 2021
Kedra, Kevin
Small-Cap Innovators Include Maker of a Better Breast Implant
September 13, 2021
Richard, Craig
Smaller Companies Filling the Void in Neuroscience Drug Development
October 01, 2020
Divan, Vamil
Midcap and Small-Cap Biopharma Opportunities a Better Way to Go in 2021
September 30, 2020
Singh, Hartaj
Capitalizing on Other Investors’ Behavioral Shortcomings
April 24, 2020
Elzahr, Michael
Looking Toward the Downtrodden Infectious Space for Opportunities
March 20, 2020
Brozak, Steve
Unmet Need and Advances in Innovation Make Neuroscience an Area for Growth
March 20, 2020
Divan, Vamil
Scrutiny of Pharmacy Benefit Managers Resulting in Visibility of Drug Prices
March 27, 2019
Brozak, Steve
The First Half of 2019 Expected to Be Rough for the Biotech Sector
March 15, 2019
Singh, Hartaj
Clinical Trial Readouts on the Horizon for NASH Monotherapies
October 05, 2018
Seedhouse, Steven
Managing Portfolios with Appropriate Asset Allocation and a Good Sell Discipline
March 14, 2018
Maxwell, Eric
Good Management Teams and Good Science are Creating Opportunities in Biotech
March 08, 2018
Singh, Hartaj
Building Portfolios with Dividend Growth and Diversification
March 10, 2017
Katz, David A.
Getting to Know High-Quality Companies and Their Fundamentals
January 27, 2017
Halliburton, Benjamin C.
Investing in Companies with Insider Buying
January 13, 2017
Boskovich Sr., Joseph M.
Investing for the Long Term in Biotechnology
October 21, 2016
Webb, Dallas
Customized Portfolio Management Based on Value and Growth at a Reasonable Price
September 23, 2016
Roberts, Mark
Seeking Income-Generating Fallen Angels
May 06, 2016
Busch, Glenn
Innovation and True Technology Solutions Key to Health Care IT Success
October 23, 2015
Rubis, Steve
Valuation a Key Investment Metric in a U.S. Value Stock Fund
June 15, 2015
Alexandra Walker-Ott
Molecular Diagnostic Companies Aim to Capitalize on Decentralized Testing
September 18, 2014
Jansen, Nicholas
Mitigating Risk Through Customized Asset Allocation
August 28, 2014
Sailer, Ryan M.
Cancer Immunotherapy a Top Focus in Biotechnology Sector
August 20, 2014
Xu, Y. Katherine
Top-Down Analysis Sets the Stage for Sector Emphasis
July 29, 2014
Burke, Frederic G.
Exercising Discipline with a Value Investing Philosophy
July 22, 2014
Elmaleh, Jacques R.
Consolidation in Medical Devices Sector Replacing R&D and Product Launches
June 20, 2014
Brozak, Steve
Applying a Size and Style Responsive Strategy for Equity Returns
June 05, 2014
Pratt, Lowell
High Success Rates and Significant M&A in the Antibody Space
April 16, 2013
Kantor, Jason
Opportunities in Hepatitis C and Genomic Technologies
April 08, 2013
Ferreiro, David
Identifying Hidden Value and Market Opportunities in Biotech Companies
March 21, 2013
Somaiya, Ian
Medical Device Companies Outperform Benchmarks Despite European Concerns
February 19, 2013
Wuensch, Joanne K.
